Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999–2003)

This publication has 13 references indexed in Scilit:

• Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001)
  Journal of Antimicrobial Chemotherapy, 2004
• bla _VIM-7 , an Evolutionarily Distinct Metallo-β-Lactamase Gene in a Pseudomonas aeruginosa Isolate from the United States
  Antimicrobial Agents and Chemotherapy, 2004
• Molecular and Biochemical Characterization of OXA-45, an Extended-Spectrum Class 2d′ β-Lactamase inPseudomonas aeruginosa
  Antimicrobial Agents and Chemotherapy, 2003
• Considerations in Control and Treatment of Nosocomial Infections Due to Multidrug‐ResistantAcinetobacter baumannii
  Clinical Infectious Diseases, 2003
• Global Epidemiology of Antimicrobial Resistance among Community-Acquired and Nosocomial Pathogens: A Five-Year Summary from the SENTRY Antimicrobial Surveillance Program (1997-2001)
  Seminars in Respiratory and Critical Care Medicine, 2003
• Evaluation of a New Etest for Detecting Metallo-β-Lactamases in Routine Clinical Testing
  Journal of Clinical Microbiology, 2002
• Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem
  Clinical Microbiology & Infection, 2002
• Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA)
  Diagnostic Microbiology and Infectious Disease, 2001
• Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
  Clinical Microbiology Reviews, 2001
• A functional classification scheme for beta-lactamases and its correlation with molecular structure
  Antimicrobial Agents and Chemotherapy, 1995